These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7144657)

  • 1. Bronchodilator solution dosage.
    Berglind BR
    Med J Aust; 1982 Oct; 2(7):314-5. PubMed ID: 7144657
    [No Abstract]   [Full Text] [Related]  

  • 2. [Basic medication of chronic obstructive lung disease with berodual].
    Melent'eva EM
    Klin Med (Mosk); 1999; 77(7):47-8. PubMed ID: 10483166
    [No Abstract]   [Full Text] [Related]  

  • 3. [Broncholytic activity of dose-adjusted aerosols in active respiratory tuberculosis].
    Vizel' AA; Iaushev MF; Mustafin RR; Goncharova LV
    Probl Tuberk; 1995; (2):7-9. PubMed ID: 7777469
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bronchodilator treatment of COPD].
    Naberan K
    Aten Primaria; 1998 Feb; 21(2):109-13. PubMed ID: 9608136
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral therapy with beta-2-sympathomimetic drugs: comparative study of the bronchospasmolytic effect of tulobuterol and fenoterol in patients with reversible airway obstruction].
    Morr H; Nink M; Ferlinz R
    Pneumologie; 1990 Apr; 44(4):739-43. PubMed ID: 2192369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current dosed aerosols in the treatment of obstructive airway diseases. 2. Bronchospasmolytics].
    Krecklow B
    Z Arztl Fortbild (Jena); 1984; 78(1):5-9. PubMed ID: 6231780
    [No Abstract]   [Full Text] [Related]  

  • 7. [The validation and procedure of inhalation therapy using 2-component aerosols in obstructive bronchopulmonary diseases].
    Ivashkin VT; Iakovlev VN; Sinopal'nikov AI; Antokhin EA
    Ter Arkh; 1993; 65(8):44-9. PubMed ID: 8211802
    [No Abstract]   [Full Text] [Related]  

  • 8. [What dosage is sufficient in combined inhalation therapy (fenoterol + ipratropium bromide) in patients with exacerbation of chronic obstructive lung disease?].
    Musil J; Hirsch V; Vondra V; Reisová M
    Vnitr Lek; 1998 Jul; 44(7):415-7. PubMed ID: 9748878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic equivalence of a fenoterol/ipratropium bromide combination (Berodual) inhaled as a dry powder and by metered dose inhaler in chronic obstructive airway disease.
    Rammeloo RH; Luursema PB; Sips AP; Beumer HM; Wald FD; Cornelissen PJ
    Respiration; 1992; 59(6):322-6. PubMed ID: 1488568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect duration and treatment effectiveness of salmeterol, fenoterol and salbutamol in severe forms of respiratory tract obstruction].
    Vollmer M; Schmidt EW; Ulmer WT
    Pneumologie; 1995 Oct; 49(10):528-34. PubMed ID: 8584522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacologic modification of effort dyspnea in children with CARA].
    Neijens HJ; Wesselius TR; Kerrebijn KF
    Ned Tijdschr Geneeskd; 1981 Aug; 125(32):1277-81. PubMed ID: 6791036
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pattern of breathing and obstruction pressure in patients with airway obstruction after inhalation of bronchodilators].
    Franczuk M; Radwan L; Maszczyk Z; Kazimierczak A; Kuś J; Koziorowski A; Kowalski J
    Pneumonol Alergol Pol; 1997; 65(7-8):457-64. PubMed ID: 9410281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-month comparative study of tulobuterol aerosol versus fenoterol aerosol in patients with chronic obstructive lung disease.
    Werdermann K
    Lung; 1990; 168 Suppl():202-9. PubMed ID: 1974678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of administration technique on bronchodilator response to fenoterol in a metered-dose inhaler.
    Rivlin J; Mindorff C; Levison H; Kazim F; Reilly P; Worsley G
    J Pediatr; 1983 Mar; 102(3):470-2. PubMed ID: 6827424
    [No Abstract]   [Full Text] [Related]  

  • 15. [Greater deterioration of lung function in COPD during continuous than during symptom-oriented bronchodilator treatment].
    Maesen BL; Maesen FP
    Ned Tijdschr Geneeskd; 1993 Jun; 137(23):1158-60. PubMed ID: 8316313
    [No Abstract]   [Full Text] [Related]  

  • 16. Fenoterol solution via nebuliser--optimum dosage.
    Harries AV; Laroche CM; Britton MG
    Eur J Respir Dis; 1987 Nov; 71(5):334-8. PubMed ID: 3443154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled fenoterol-ipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary disease.
    Guerin C; Chevre A; Dessirier P; Poncet T; Becquemin MH; Dequin PF; Le Guellec C; Jacques D; Fournier G
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1036-42. PubMed ID: 10194143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual results of treatment of COPD with low doses of fenoterol compared with treatment with ipratropium bromide.
    Hodzhev B; Kostianev S; Todorov I; Belev G; Kartev S
    Folia Med (Plovdiv); 1999; 41(4):46-52. PubMed ID: 10786204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nebulized fenoterol on spirometry, dyspnea sensation changes during exercise in patients with chronic obstructive pulmonary disease.
    Chiang LL; Yu CT; Kuo HP
    Changgeng Yi Xue Za Zhi; 1996 Jun; 19(2):129-34. PubMed ID: 8828254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilator effect and serum theophylline level after combined treatment with fenoterol and theophylline in reversible chronic airflow obstruction.
    Lucena MI; Almagro J; Rius F; Sanchez de la Cuesta F
    Eur J Clin Pharmacol; 1988; 35(6):669-71. PubMed ID: 3234474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.